Copoly.ai

Detect Cancer Earlier Blood-Based Multi-Cancer Early Detection Empowering clinicians and patients with earlier, more accurate cancer detection Discover OncoSage AI-Powered Productivity Enterprise AI Assistant for Modern Teams Streamlining workflows and accelerating decision-making for government agencies and enterprise organizations Explore OfficeSage Strategic AI Consulting Transform Your Business with Intelligent AI Strategy Helping organizations assess AI readiness, design adoption roadmaps, and build competitive advantage through AI Start a Conversation Bioinformatics Expertise Advanced Computational Biology and Multi-Omics Solutions Accelerating research and discovery with advanced computational biology and AI-powered scientific services Explore Our Services Slider1 Slider1

Pioneering AI Solutions for Health and Business

Who We Are

Copoly is a Canadian biopharma AI company on a mission to make life-saving technology accessible and intelligent. We build products and services that sit at the intersection of artificial intelligence, clinical science, and enterprise productivity — helping healthcare providers detect cancer earlier, organizations work smarter, and research teams move faster.

From our flagship cancer detection platform to enterprise AI tools and deep bioinformatics consulting, everything we do is driven by one belief: that AI should solve real problems for real people.

Advancing Health and Business Through AI

Our Offerings
  • OncoSage

    A blood-based multi-cancer early detection platform built for clinicians, hospitals, and researchers who need accurate, timely results when it matters most.

  • OfficeSage

    An enterprise AI productivity assistant built for government agencies and large organizations. Streamlines workflows, accelerates decision-making, and integrates securely within your existing infrastructure.

  • Consultation Hub

    From AI readiness assessments and implementation roadmaps to computational biology and bioinformatics services — tailored to your organization's needs.

Detect Cancer Earlier with OncoSage

Blood-Based Cancer Detection

OncoSage is Copoly’s flagship multi-cancer early detection platform. Designed to deliver fast, accurate results from a single blood draw, it gives clinicians and patients a critical head start in the fight against cancer.

Designed for hospitals, diagnostic labs, and research institutions who need accuracy, speed, and clinical credibility in one platform.

Work Smarter with OfficeSage

Enterprise AI Productivity

OfficeSage is Copoly’s enterprise AI assistant — built from the ground up for the demands of government agencies, large enterprises, and operations teams who need secure, reliable, and intelligent productivity tools.

From document analysis and workflow automation to decision support and knowledge management — OfficeSage brings the power of AI into your daily operations without compromising security or compliance.

Trusted by Researchers, Clinicians and Government

Recognition & Impact

40+

Happy Clients

120+

Combined Years of Expertise

12+

Active Engagements

85+

Successful Deliverables

Latest News and Insights

From Our Blog

Copoly: Leading the Charge in Early Cancer Detection through Multi-Omics and AI

By Dr. Piru Perampalam, Chief Scientific Officer, and Giselle Bagatini, Chief AI Officer, Copoly The fight against cancer is one of the most challenging and critical battles in modern medicine.…

Copoly Selected for Startup Showcase Talk at Collision 2024

Toronto, ON – June 11, 2024 – Copoly is proud to announce that we have been selected to deliver a Startup Showcase talk at Collision 2024, one of the world’s…

Addressing the Challenge: 50% of Cancers are Diagnosed Too Late

Cancer is a global health crisis, affecting millions of people every year. Despite advancements in medical research and technology, an alarming statistic persists: approximately 50% of cancers are diagnosed at…

Copoly Selected for ALPHA Program at Collision 2024 in Toronto

Toronto, ON – May 17, 2024 – Copoly, a pioneering leader in cancer diagnostics and biomedical research, is thrilled to announce its selection for the prestigious ALPHA program at Collision…

The Transformative Power of Early Cancer Detection in Improving Patient Outcomes

Cancer remains one of the leading causes of mortality worldwide, with millions of new cases diagnosed each year. Early detection of cancer can significantly improve patient outcomes by enabling timely…